Elisabet
Guruceaga Martínez
Bioinformática
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (2)
2019
-
Inhibitor of differentiation-1 sustains mutant KRAS-driven progression, maintenance, and metastasis of lung adenocarcinoma via regulation of a FOSL1 network
Cancer Research, Vol. 79, Núm. 3, pp. 625-638
2016
-
Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study
European Journal of Haematology, Vol. 97, Núm. 2, pp. 128-136